Nanobac Pharmaceuticals, Incorporated (NNBP)

Market Cap	250.00
Revenue (ttm)	17.62K -92.2%
Net Income	-6.58M
EPS	-0.03
Shares Out	249.51M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,000
Open	0.000001
Previous Close	n/a
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.0001
Beta	-53.41
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Nanobac Pharmaceuticals

Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It manufactures and markets in vitro diagnostic (IVD) kits, such as assays, antibodies, and reagents for detecting CNPs. The company’s diagnostic assays comprise NANO-CAPTURE and NANO-SERO. Additionally, it conducts research and clinical studies in the development of urological diseases, including chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and pol...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1994
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: NNBP

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 19, 2026

Data Sources Report a data error